The UN General Assembly Special Session on Non-Communicable Diseases this September offers an all-too-rare window of opportunity to push cancer well up the global health agenda. Read more to see how you can help! Download [more]
Paediatric oncologists have a well-deserved reputation for collaborating and treating patients within trial protocols, but there are limits to what they can achieve alone. Download full article
Triple negative breast cancers, as a subgroup, are associated with a poor prognosis. But different subtypes within triple negative disease are associated with different outcomes… Download full article
The concept of a genomic signature that can define any tumour according to its unique biology has been central to the emerging paradigm of personalised therapy. But how helpful are multi-gene assays in guiding treatment [more]
The plight of cancer patients for whom treatment means risking losing the opportunity to have children was taken up in a piece that earned Sławomir Zagórski a BCRA. Download full article
Stan Kaye, head of drug development at the Royal Marsden treasures the moments when a new drug turns up that shows real value. The big challenge is to understand who benefits from what. Download full [more]
Women with advanced breast cancer can live a full and active life. But median survival is still hovering around three years and progress is frustratingly slow. A new conference now seeks to change this. Download [more]
Oncologists wanting to develop and work can find it hard to balance the competing priorities of clinical practice and study. This new online MSc in Advanced Oncology run by the University of Ulm may be [more]
A randomised phase III trial of patients with stage II and III colon cancer showed no benefit of adding bevacizumab to standard adjuvant oxaliplatin plus fluorouracil and leucovorin. Despite suggestive evidence of a short-term benefit, [more]
One of the seven ongoing trials of accelerated partial breast irradiation (APBI) has concluded that single-dose intraoperative radiotherapy should be considered as an alternative to protracted whole-breast irradiation. With a median follow up of two [more]
Selected reports edited by Janet Fricker Download full article